NEW YORK ( TheStreet) -- Shares of Cyclacel Pharmaceuticals (Nasdaq: CYCC) were gapping down Monday morning with an open price 10.3% lower than Friday's closing price. The stock closed at 87 cents Friday and opened today's trading at 78 cents. The average volume for Cyclacel has been 831,500 shares per day over the past 30 days. Cyclacel has a market cap of $38.7 million and is part of the health care sector and drugs industry. Shares are down 40.8% year to date as of the close of trading on Friday. Cyclacel Pharmaceuticals, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of mechanism-targeted drugs to treat human cancer and other serious disorders. TheStreet Ratings rates Cyclacel as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full Cyclacel Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting DOWN to 95370 or select from multiple alert options.